# Delaware Christiana Care NCORP

> **NIH NIH UG1** · CHRISTIANA CARE HEALTH SERVICES, INC. · 2023 · $1,798,153

## Abstract

Project Summary/Abstract
Delaware/Christiana Care (CCHS) National Cancer Institute Oncology Research Program
(NCORP) was originally funded as a Community Clinical Oncology Program (CCOP) in 1987,
was funded as a NCI Community Cancer Centers Program (NCCCP) beginning in 2007 and
continued participation as an NCORP in 2014 through the present. CCHS has been an
exemplary contributor to all programs, frequently recognized for high accruals,stellar data
quality and timeliness of submissions. Currently, CCHS participates in the ALLIANCE, ECOG-
ACRIN, NRG, Wake Forest and Rochester cooperative groups with approximately 80 trials
opened to accrual. Participation in CTSU and the CIRB is active and ongoing. Our catchment
area includes all of Delaware and portions of New Jersey, northeastern Maryland and
southeastern Pennsylvania. Our NCORP includes two affiliates, Beebe Health Care and
Nanticoke Memorial, both located in southern Delaware. Our communities represents a
popluation base in excess of 2 million people with extensive protocol entry potential. Under the
leadership of Gregory Masters, M.D, Principal Investigator and Kandie Dempsey, DBA, MS, RN,
OCN, Director, NCORP investigators and support professionals will continue to participate in
NCTN core committees and leadership positions. Currently, our physician researchers are
represented with appointments to 17 NCORP committees and 3 NCI Steering Committees
(Breast, Gynecological and Imaging). Our mission is to continue accruals to both treatment and
cancer control studies and to further develop Cancer Care Delivery Research (CCDR)
participation which will build upon the intiatives set forth with our collaboration the NCI. Every
patient at the Helen F. Graham Cancer Center & Research Institute (HFGCCRI) is evaluated for
clinical trial participation. We anticipate dedicating at minimum 10% of our activities towards
CCDR to include scientific investigation of the complexities of social factors, organizational
structures and processes, health technologies, access to cancer care, quality and cost factors,
disparties in our community. And will examine the feasibility of examining financial costs of care
and health technology systems as part of the CCDR program. The overall impact of this grant
will be to ensure continuation and stimulate expansion of NCORP activities, including treatment
and cancer control research, at CCHS and its affiliates. The Delaware/CCHS NCORP has
consistently rated amongst top in the nation for clinical trial accruals. Over the past three years
the accrual rate has been 21.1% in 2015, 26.3% in 2016 and 27.4% in 2017.

## Key facts

- **NIH application ID:** 10673634
- **Project number:** 5UG1CA189819-10
- **Recipient organization:** CHRISTIANA CARE HEALTH SERVICES, INC.
- **Principal Investigator:** GREGORY A MASTERS
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $1,798,153
- **Award type:** 5
- **Project period:** 2014-08-01 → 2025-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10673634

## Citation

> US National Institutes of Health, RePORTER application 10673634, Delaware Christiana Care NCORP (5UG1CA189819-10). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10673634. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*